Mesoblast reported 10.46M in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
Avita Medical AUD 1.35M 230K Jun/2024
Clinuvel Pharmaceuticals 2.43M 414.48K Jun/2024
Cochlear AUD 5.7M 800K Dec/2024
CSL USD 240M 18M Dec/2024
Paradigm Biopharmaceuticals AUD 4K 2.48K Jun/2024
PYC Therapeutics AUD 6K 30.66K Jun/2024
Ramsay Health Care AUD 305.7M 700K Dec/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Telix Pharmaceuticals AUD 3.39M 2.92M Dec/2024